Osteoboost Health

Osteoboost Health

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://osteoboost.com

Last Round

Series A-prime

Apr 15, 2026

Est. Valuation

$25M

Total Funding Raised

$18.2M

Company Overview

Osteoboost Health is a medical technology company that has developed Osteoboost, an FDA-cleared, prescription wearable device using vibration therapy to slow bone density loss in postmenopausal women with osteopenia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

wearable vibration therapyosteopenia treatmentbone density deviceFDA-cleared medical devicefemtechnon-pharmacological treatmentosteoporosis preventionpostmenopausal healthat-home medical devicedigital healthdirect-to-consumer medical devicehealth IoTtelehealth prescriptionRemote Therapeutic MonitoringRTMfall prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osteoboost Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Osteoboost Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A-primeApr 15, 2026
Series A ExtensionMar 4, 2024
GrantOct 6, 2021
Series AMay 3, 2021

Key People

Founding team and executive leadership

Laura Yecies

Chief Executive Officer And Board Member, Board Member

Executive Team

Pamela M. Peeke

Chief Medical Officer

Executive Team

Priya Patel

Chief Product Officer, Chief Product Officer

Executive Team

Osteoboost Health Investors

Notable investors and investment history

InvestorRounds
Emmeline VenturesSeries A-prime
Good Growth CapitalSeries A Extension, Series A-prime, Series A
Disrupt Health Impact FundSeries A-prime
IT-Farm CorporationSeries A
AgeTech CollaborativeSeries A-prime
Portfolia Femtech FundSeries A
Astia AngelsSeries A, Series A Extension, Series A-prime

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Partnered with Midi Health for a public webinar on HRT and bone health.

  • Apr 15, 2026

    Raised $8M in early funding.

Osteoboost Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Osteoboost Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Osteoboost Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range21
Year Founded2018
Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.